Sami Ventelä and Jukka Westermarck recognized by Medical Association Duodecim for their influential work.
Medical association Duodecim selects each year persons that have been most influential in the field of medicine. This year´s list included two group leaders from Turku Bioscience Centre, Docent Sami Ventelä and Professor Jukka Westermarck. They both were awarded in the category of ”Scientific pioneers” (Tieteelliset tienraivaajat). The news and all awardees can be found >>here (in Finnish).

Sami Ventelä (left) and Jukka Westermarck (right)
Sami Ventelä
“Ventelä treats cancer patients at Turku University Hospital and leads a research group at the Turku Bioscience Centre. He has assembled a globally unique collection of patient material on head and neck cancers, through which Ventelä has made several significant new diagnostic discoveries that have been published in the field’s leading journal series. This year, he demonstrated the significant diagnostic role of the LIMA1 protein in selecting treatment for patients with head and neck cancer.”
Jukka Westermarck
“Professor of Cancer Biology at the University of Turku and Research Director at the Turku Bioscience Centre. He is one of Finland’s leading cancer researchers, whose research group has for more than 20 years investigated the signal transduction of cancer cells. In addition, he is an active advocate for science and research, emphasizing the importance of scientific work from the perspectives of society, healthcare, and the economy.”
Recent Posts
- Meet our SAB over lunch!Turku Bioscience and BioCity Turku Scientific Advisory Board (SAB) is visiting Turku next week, and Read moreSeptember 16, 2026
- Dissertation Defence: Eleftheria MaranouMSc Eleftheria Maranou, from affiliated MIORG group, succesfully defended the dissertation in Immunology titled “The Achilles’ heel of Read moreSeptember 1, 2026
- Researchers discover molecular mechanism that helps aggressive colorectal cancer to spreadResearchers from the University of Turku in Finland, Turku Bioscience Centre and Gustave Roussy Institute Read moreAugust 25, 2026
- The Novo Nordisk Foundation has awarded funding of approximately one million euros to a research project led by Professor Jukka WestermarckThe Novo Nordisk Foundation has awarded funding of approximately one million euros to a research Read moreAugust 21, 2026
- The Jane and Aatos Erkko Foundation has granted nearly €1 million to support research led by Professor Jukka Westermarck993 000 € was granted to a research project led by our Group Leader Professor Jukka Read moreApril 2, 2026
- Cecilia Sahlgren’s group discovers a new mechanism driving breast cancer progressionOur affiliated research group led by Professor Cecilia Sahlgren at Åbo Akademi University and the InFLAMES Research Read moreMarch 25, 2026